Mak Calvin Hoi Kwan, Lu Yeow Yuen, Wong George Kwok Chu
Department of Surgery, Prince of Wales Hospital, Shatin, Hong Kong.
Vasc Health Risk Manag. 2013;9:353-9. doi: 10.2147/VHRM.S34046. Epub 2013 Jul 11.
Intracranial hypertension is commonly encountered in poor-grade aneurysmal subarachnoid hemorrhage patients. Refractory raised intracranial pressure is associated with poor prognosis. The management of raised intracranial pressure is commonly referenced to experiences in traumatic brain injury. However, pathophysiologically, aneurysmal subarachnoid hemorrhage is different from traumatic brain injury. Currently, there is a paucity of consensus on the management of refractory raised intracranial pressure in spontaneous subarachnoid hemorrhage. We discuss in this paper the role of hyperosmolar agents, hypothermia, barbiturates, and decompressive craniectomy in managing raised intracranial pressure refractory to first-line treatment, in which preliminary data supported the use of hypertonic saline and secondary decompressive craniectomy. Future clinical trials should be carried out to delineate better their roles in management of raised intracranial pressure in aneurysmal subarachnoid hemorrhage patients.
颅内高压在低级别动脉瘤性蛛网膜下腔出血患者中很常见。难治性颅内压升高与预后不良相关。颅内压升高的管理通常参考创伤性脑损伤的经验。然而,从病理生理学角度来看,动脉瘤性蛛网膜下腔出血与创伤性脑损伤不同。目前,对于自发性蛛网膜下腔出血中难治性颅内压升高的管理缺乏共识。我们在本文中讨论高渗药物、低温、巴比妥类药物和去骨瓣减压术在治疗一线治疗难治性颅内压升高方面的作用,其中初步数据支持使用高渗盐水和二期去骨瓣减压术。未来应开展临床试验,以更好地明确它们在动脉瘤性蛛网膜下腔出血患者颅内压升高管理中的作用。